Medical devices are becoming more connected than ever before. From cloud-based monitoring systems to mobile health applications and hospital networks, connectivity improves patient care but also increases cybersecurity risks. Cyberattacks on healthcare systems have demonstrated that vulnerable medical devices can impact patient safety, disrupt clinical operations, and expose sensitive health information.
To address these risks, the U.S. Food and Drug Administration (FDA) requires manufacturers to demonstrate that cybersecurity has been integrated throughout the device lifecycle. The FDA cybersecurity checklist helps manufacturers prepare the documentation, testing evidence, and risk management activities needed for successful regulatory submissions.
What Is the FDA Cybersecurity Checklist?
The FDA cybersecurity checklist is a structured framework that helps medical device manufacturers verify whether they have addressed all cybersecurity requirements before submitting a 510(k), De Novo, or PMA application.
The checklist typically covers:
Cybersecurity risk assessments
Threat modeling activities
Secure product design controls
Software Bill of Materials (SBOM)
Vulnerability management processes
Security testing and validation
Patch and update mechanisms
Postmarket monitoring plans
Regulatory documentation and traceability
By following a comprehensive checklist, manufacturers can reduce regulatory delays and ensure their devices meet FDA cybersecurity expectations.
Why Cybersecurity Matters for Medical Devices
Modern medical devices often connect to multiple external systems, creating larger attack surfaces for cybercriminals. A security vulnerability in a connected infusion pump, patient monitor, or diagnostic device can affect both device performance and patient safety.
The FDA considers cybersecurity an essential component of device safety and effectiveness. Manufacturers are expected to identify potential threats, evaluate their impact on patients, and implement appropriate safeguards before devices reach the market.
FDA Cybersecurity Checklist: Key Requirements
1. Conduct Cybersecurity Risk Assessment
A cybersecurity risk assessment forms the foundation of FDA compliance. Manufacturers must identify potential threats, vulnerabilities, and attack paths that could affect device functionality or patient outcomes.
The assessment should include:
Threat identification
Vulnerability analysis
Risk prioritization
Patient safety impact evaluation
Risk mitigation strategies
The FDA expects device-specific assessments rather than generic cybersecurity documentation.
2. Perform Threat Modeling
Threat modeling helps manufacturers understand how attackers might exploit weaknesses within a device ecosystem.
Effective threat modeling should:
Identify critical assets
Map data flows
Analyze attack vectors
Evaluate trust boundaries
Document mitigation controls
Threat modeling demonstrates that cybersecurity risks were considered during product design rather than after development was completed.
3. Implement Secure Design Controls
Cybersecurity should be built into the device architecture from the beginning.
Common secure design practices include:
Strong authentication mechanisms
Role-based access controls
Encryption of sensitive data
Secure communication protocols
Secure software development practices
The FDA recommends incorporating cybersecurity controls throughout the product development lifecycle.
4. Create a Software Bill of Materials (SBOM)
An SBOM provides visibility into all software components used within a medical device, including open-source and third-party libraries.
An effective SBOM helps manufacturers:
Track software dependencies
Identify vulnerable components
Improve vulnerability response times
Maintain transparency during regulatory review
SBOMs have become a critical part of FDA cybersecurity submissions.
5. Conduct Security Testing
Security testing provides evidence that cybersecurity controls function as intended.
Testing activities commonly include:
Vulnerability assessments
Penetration testing
Security verification testing
Interface testing
Network security testing
Manufacturers should document findings, remediation actions, and residual risks.
6. Manage Third-Party Software Risks
Many medical devices rely on operating systems, libraries, cloud services, and external software components.
Manufacturers should:
Maintain inventory of third-party components
Monitor known vulnerabilities
Establish patch management procedures
Evaluate supplier security practices
Third-party software risks must be addressed throughout the device lifecycle.
7. Develop a Postmarket Cybersecurity Plan
Cybersecurity responsibilities continue after FDA clearance or approval.
A strong postmarket plan should include:
Vulnerability monitoring
Incident response procedures
Coordinated vulnerability disclosure processes
Security update deployment
Ongoing risk assessment
The FDA expects manufacturers to actively monitor and address cybersecurity vulnerabilities after commercialization.
Common Mistakes That Delay FDA Review
Many submissions experience delays because of:
Incomplete threat modeling documentation
Missing SBOMs
Weak penetration testing evidence
Poor traceability between risks and controls
Insufficient vulnerability management procedures
Lack of postmarket cybersecurity planning
Addressing these gaps early can significantly improve submission readiness.
How Qualysec Helps Medical Device Manufacturers
Qualysec supports medical device companies by providing end-to-end cybersecurity services aligned with FDA expectations. These services include threat modeling, risk assessments, penetration testing, vulnerability management, SBOM preparation, and regulatory documentation support.
By combining technical security testing with regulatory expertise, manufacturers can build stronger cybersecurity programs and prepare more complete FDA submissions.
Conclusion
The FDA cybersecurity checklist is more than a regulatory requirement—it is a roadmap for building secure and resilient medical devices. By focusing on risk assessment, threat modeling, secure design, SBOM management, security testing, and postmarket monitoring, manufacturers can improve patient safety while reducing regulatory risk.
Organizations that integrate cybersecurity throughout the product lifecycle are better positioned to achieve faster FDA reviews, stronger compliance outcomes, and greater trust from healthcare providers and patients.
Top comments (0)